Secondary Logo

Journal Logo

May 1996 - Volume 19 - Issue 3
pp: 169-243

PDF Only


Anti-Renal-Cell Carcinoma Chimeric Antibody G250 Facilitates Antibody-Dependent Cellular Cytotoxicity with In Vitro and In Vivo Interleukin-2-Activated Effectors

Surfus, Jean E.; Hank, Jacquelyn A.; Oosterwijk, Egbert; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(3):184-191, May 1996.


PDF Only


Analysis of Expression of the Melanoma-Associated Antigens MART-1 and gp lOO in Metastatic Melanoma Cell Lines and in In Situ Lesions

Marincola, Francesco M.; Hijazi, Yasmine M.; Fetsch, Patricia; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(3):192-205, May 1996.

Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic Melanoma

Murray, James L.; Kleinerman, Eugenie S.; Jia, Shu-Fang; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(3):206-217, May 1996.

Treatment of Stage IIIB Non-Small-Cell Lung Cancer with Surgery Followed by Infusion of Tumor Infiltrating Lymphocytes and Recombinant Interleukin-2: A Pilot Study

Melioli, Giovanni; Ratto, Giovanni Battista; Ponte, Marco; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 19(3):224-230, May 1996.